drugset

drugset / Trial / NCT01080716

Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate

NCT01080716 ↗

Phase 1/2 Completed 30 enrolled U.S. Army Medical Research and Development Command Mahidol University · collab National Institutes of Health (NIH) · collab

RandomizedParallel-groupTriple-blindPrevention

Summary

This study is an inpatient trial to determine the safety, immunogenicity and efficacy of the WRSS1 candidate vaccine in healthy Thai adult volunteers.

Timeline

Start: 2010-05
Primary completion: 2010-09
Completion: 2011-12

Publications

Pitisuttithum P, Islam D, Chamnanchanunt S, Ruamsap N, Khantapura P, Kaewkungwal J, Kittitrakul C, Luvira V, Dhitavat J, Venkatesan MM, Mason CJ, Bodhidatta L. Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults. Clin Vaccine Immunol. 2016 Jul 5;23(7):564-75. doi: 10.1128/CVI.00665-15. Print 2016 Jul.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	WRSS1	Vaccine	16000 unknown	Oral

Indications